Genetic Imputation
Gain a competitive edge with our one-of-a-kind AI-powered genetic imputation technology. Maximize the potential of your DNA kit data by imputing 200+ million genetic variants with 99.99% accuracy.
Book a callLeverage the power of whole genome sequencing for a fraction of the cost
Leverage the power of whole-genome sequencing at the cost of genotyping with unmatched accuracy. OmicsEdge’s industry-leading AI-powered imputation algorithm outperforms top competitor models, especially in predicting rare variants, solidifying our position as global leaders in advanced genetic technologies. Discover how OmicsEdge’s imputation technology can help your business gain a competitive advantage by providing precise genetic insights, enhancing your research capabilities, and expediting genomic developments with a plug-and-play API or turn-key solutions.
Book a call
How It Works
Provide Genetic Data
Upload raw genetic data to our platform or take advantage of our CLIA/CAP certified DNA test kit.
Perform Imputation
OmicsEdge will impute up to 200M genetic variants with unparalleled accuracy for polygenic testing or other analysis. Receive the raw imputed data or take advantage of our other DNA-based services.
Go Deeper With Precision Testing
Take advantage of OmicsEdge’s other capabilities, such as ancestry-informed polygenic risk score reports, lab & lifestyle analysis and our state of the art recommendations engine to provide true precision health insights & recommendations.
Boost Your Research with
OmicsEdge’s Superior Genetic
Imputation Model
As a health technology service provider, you understand the need for cutting-edge solutions that deliver both innovation and cost-efficiency. OmicsEdge offers you just that with Selphi, our groundbreaking genotype imputation tool that bridges the gap between affordability and the comprehensive insights of whole genome sequencing (WGS).
Why Choose Selphi for Your Genomic Projects? Unmatched Cost Efficiency and Comprehensive Data
While whole genome sequencing provides a complete picture of genetic variation, its high costs make it impractical for large-scale applications. Most large genomics projects opt for genotyping arrays, which are more affordable but capture fewer variants. Here’s where Selphi comes in—our advanced imputation model transforms the limited data from genotyping arrays into a comprehensive genetic profile, delivering WGS-level insights at a fraction of the cost.
Superior Imputation Accuracy for Reliable Results
Imputation accuracy is the backbone of any genomic analysis. Selphi is designed to exceed expectations, offering unmatched precision in predicting missing genetic variants. As demonstrated in Figure 1, Selphi consistently outperforms other leading imputation methods across all allele frequencies, especially excelling with rare variants that are often crucial for identifying medically significant traits. This accuracy ensures your products can deliver high-quality, actionable insights to your customers.
Inclusive Performance Across Diverse Populations
Diversity matters in genomics. Selphi’s performance isn’t limited to a single population; it’s been rigorously tested and proven to deliver superior results across diverse super populations, including Africans, East and South Asians, and Europeans. This means you can trust Selphi to provide reliable and comprehensive insights, regardless of your customer base’s genetic background.
Gain a Competitive Edge with OmicsEdge’s Selphi
Integrating Selphi into your health tech products not only enhances the quality of your offerings but also positions your company as a leader in the rapidly evolving field of personalized medicine. Provide your customers with the most accurate, comprehensive genetic insights available—without the prohibitive costs of whole genome sequencing.
Don't settle for genomics solutions that focus on a handful of SNPs. Enhance your products with OmicsEdge's Selphi and empower your customers with unparalleled genomic insights.
Fig.1 | Selphi vs. state-of-the-art imputation methods. The difference in imputation errors across chromosomes 1-22 between Beagle 5.4 (blue), Impute 5 (magenta), Minimac 4 (yellow), and Selphi (green) binned by minor allele frequency (MAF) (a) and in different super populations (b). This difference is shown as the ratio (fold change) or the deviation from the average number of errors across all four methods. Target and reference samples were obtained from the 1KGP 30x reference panel. Selphi outperforms the other methods for all MAF bins and all four 1KGP super populations; being particularly better at imputing rare variants (MAF < 1%).
The OmicsEdge Advantage
- World's most accurate polygenic risk scores
- World's largest health recommendations engine
- AI-driven patent pending technology
- Algorithms validated on datasets of 2M+ people
- Ancestry-adjusted risk scores for unmatched accuracy
- Built by a team of 60+ scientists and engineers
- Trusted by the thousand of doctors and leading health tech companies.
- HIPAA & GDPR compliant
- Validated & peer-reviewed in 6 scientific papers